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Background: There is increasing evidence that more aggressive 
pain management is needed in patients undergoing craniotomy in 
Korea.  However, no consensus or standardized analgesic regimen 
has been established to date.  To achieve this consensus, we 
undertook a survey of the current state of post-craniotomy pain 
management in Korea.
Methods: A postal questionnaire was sent to anesthesiologists, 
neurosurgeons and nurses of neurosurgical departments at 44 
university hospitals in Korea.  Of the 44 centers that were sent 
questionnaires, 35 centers returned these from their anesthesiology 
department resulting in a response rate of 73%, and 25 returned 
the questionnaires from their neurosurgery department (response 
rate: 57%).  
Results: Fifty-three percent of neurosurgeons answered that current 
postoperative pain management was adequate after craniotomy, 
whereas only 8% of anesthesiologists agreed.  However, 72% of 
neurosurgeons also agreed that a more aggressive pain mana-
gement was needed for post-craniotomy patients.  Fifty-two percent 
and 23% of neurosurgeons used non-steroidal anti-inflammatory 
drugs (NSAIDs) and acetaminophen as a first-line analgesic, 
respectively.  Twenty-five percent of neurosurgeons used opioids 
as a first-line analgesic.  Fifty percent of anesthesiologists used 
strong opioids alone or with NSAIDs as a first-line analgesic.  About 
10% of both groups used weak opioids as a first-line drug.  
Conclusions: Many clinicians agree that post-craniotomy pain is 
not adequately managed and more aggressive strategies are 
needed.  Nevertheless, opioid analgesics are still avoided because 
of the concern of side effects despite no evidence to suggest 
increased risk when use carefully.  (Anesth Pain Med 2011; 6: 
362∼367)
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INTRODUCTION
  It was traditionally considered that patients undergoing 
craniotomy surgery experienced minimal pain postoperatively.  
This original understanding that post-craniotomy patients have 
minimal pain has since changed. Studies have shown that 
patients undergoing craniotomy surgery experience varying 
degrees of pain postoperatively from mild discomfort to severe 
pain [1-3]. It is now known that pain after craniotomy is 
common and has consequently received increased attention. 
  In several surveys, many clinicians felt that postoperative 
analgesia for craniotomy patients was inadequate and still 
poorly managed and undertreated [2,4-6]. Codeine shows 
inadequate analgesia in craniotomy patients and the use of 
more potent analgesics such as morphine is recommended [7]. 
Nevertheless, the majority of clinicians still use the weak 
opioid codeine as a first-line analgesic after craniotomy [4,6] 
because strong opioids have harmful effects on neurosurgical 
patients. 
  Opioids may produce sedation and miosis leading to an 
impaired neurologic examination [5]. Opioids may depress 
respiration, leading to hypercapnia and increased intracranial 
blood volume [8]. However, it was recently shown that 
morphine has superior analgesia effects to both tramadol and 
codeine in craniotomy patients without increasing side effects 
[9,10]. Furthermore, patient-controlled analgesia (PCA) using 
opioid analgesic is widely used after surgery. However, PCA 
is not commonly used in patients undergoing craniotomy 
surgery. Recent studies suggested that PCA is a useful option 
in craniotomy patients and more effective than other methods 
[11-13]. 
  There is increasing evidence that more aggressive pain 
management is needed in patients undergoing craniotomy in 
Korea. However, no consensus or standardized analgesic regime 
has been established to date. Consensus between clinicians 
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Table 1. Different Opinions of Current Pain Management for Patients Undergoing Craniotomy
Current pain management is adequate Yes No N/A
　Neurosurgeon
　Anesthesiologist
53%
8%
31%
65%
16%
27%
More aggressive pain management is needed Yes No N/A
　Neurosurgeon
　Anesthesiologist
72%
88%
18%
5%
10%
7%
Main problem that aggressive pain management is not carried out
Minimal pain Side effects of opioid Difficulties in pain management N/A
　Neurosurgeon
　Anesthesiologist
21%
9%
45%
65%
12%
10%
22%
16%
N/A: not available. 
about post-craniotomy pain management is needed the most to 
introduce a formal analgesic regime. For achieving this 
consensus, we undertook a survey of the current state of 
post-craniotomy pain management in Korea.
MATERIALS AND METHODS
  A postal questionnaire (Appendix) was sent to anesthesio-
logists, neurosurgeons and nurses of neurosurgical departments 
in 44 university hospitals in Korea. A total of 20 question-
naires were sent to each hospital.
  The questionnaire consisted mainly of 4 parts, which inclu-
ded the personal opinions of current pain management after 
craniotomy, the current state of pain management in their 
hospitals, routine assessment of pain after craniotomy, and 
experience of chronic pain. Finally, additional questions were 
asked from anesthesiologists only for the use of PCA 
(Appendix: question 11 and 12).  
RESULTS
  Of the 44 centers that were sent questionnaires, 35 centers 
returned these from their anesthesiology department resulting in 
a response rate of 73%, and 25 returned the questionnaires 
from their neurosurgery departments (response rate: 57%). A 
total of 359 questionnaires were used for the data analysis. 
  None of the hospitals appeared to have a standardized 
regime or protocol for post-craniotomy pain management. 
Furthermore, the analgesic regime was different for clinicians 
even in the same hospital. Therefore, we analyzed the data by 
two groups instead of by each hospital, which were the 
neurosurgeon group and the anesthesiologist group. Data from 
nurses (48 questionnaires in 18 centers) were only used for 
pain assessment in the wards or neurosurgical intensive care 
unit.
  Fifty-three percent of neurosurgeons answered that current 
postoperative pain management was adequate after craniotomy, 
whereas only 8% of anesthesiologists agreed. However, 72% of 
neurosurgeons also agreed that more aggressive pain manage-
ment was needed for post-craniotomy patients (Table 1). 
  The reasons why more aggressive pain management was not 
carried out in post-craniotomy patients included adverse effects 
of opioid analgesics (45% of neurosurgeons, 65% of ane-
sthesiologists), minimal pain after craniotomy (21% of neuro-
surgeons and 9% of anesthesiologists) and annoyances in 
managing opioids and pain control apparatus (12% of neuro-
surgeons and 10% of anesthesiologists) (Table 1).
  Fifty-two percent and 23% of neurosurgeons used non- 
steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen 
as a first-line analgesic, respectively. Twenty-five percent of 
neurosurgeons used opioids as a first-line analgesic, 48% of 
which were weak opioids such as codeine or tramodol and 
52% strong opioids such as fentanyl or morphine. Sixty 
percent of anesthesiologists used opioids alone or with NSAIDs 
as a first-line analgesic, 17% of which were weak opioids and 
83% strong opioids. About 10% of both groups used weak 
opioids as a first-line drug (Table 2).
  If additional analgesics were needed for pain management, 
75% of both neurosurgeons and anesthesiologists used opioids. 
Fifty percent of neurosurgeons used weak opioids as the 
additional opioid analgesic compared to only 19% of anesthe-
siologists. Fentanyl is the most frequently used strong opioid 
analgesic in both groups (Table 2). 
  Most hospitals used the intermittent intravenous or intra-
muscular bolus injection method for drug delivery, while 6 
hospitals sometimes used intravenous patient-controlled anal-
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Table 2. Current State of Various Pain Management Strategies
First-line analgesics Acetaminophen(paracetamol) NSAIDs Weak opioid Strong opioid NSAIDs ＋ strong opioids
　Neurosurgeon
　Anesthesiologis
23%
2%
52%
38%
12%
10%
7%
43%
6%
7%
Additional analgesics
 (2nd line) Acetaminophen NSAIDs Opioids No addition
　Neurosurgeon
　Anesthesiologis
3%
0%
20%
17%
75%
75%
2%
2%
Opioid analgesics Weak opioid Morphine Fentanyl Reminfentanil Others
　Neurosurgeon
　Anesthesiologist
50%
19%
21%
18%
23%
53%
2%
3%
6%
7%
NSAIDs: Non-steroidal anti-inflammatory drugs.
gesia (PCA) on a case by case basis. One hospital used 
additional regional block or local infiltration combined with an 
intermittent bolus injection.
  Forty-eight percent of neurosurgeons prescribed analgesics at 
regular intervals in the ward or at ICU, with 52% prescribing 
analgesia as required.
  Almost all respondents (85% neurosurgeons, 89% anesthesio-
logists and 89% nurses) answered that regular pain assessment 
is necessary in post-craniotomy patients. Routine pain assess-
ment in post-craniotomy patients was performed in 48% of the 
hospitals (17/35 hospital). In the remaining 18 hospitals, pain 
assessment was performed only when patients complained of 
pain. The majority of hospitals that performed pain assessment 
used the numeric rating scale (NRS, 88%) while the remainder 
used the visual analogue scale (VAS, 12%). However, routine 
formal pain assessment in patients with impaired com-
munication was hardly performed, except for face legs activity 
cry consolability scale (FLACC) at some instances. Seventy- 
one percent of neurosurgeons had experience with patients who 
complained of chronic pain after craniotomy.
  In 33 hospitals (91%), postoperative pain management was 
mainly performed by neurosurgeons after craniotomy. The main 
reasons why anesthesiologists did not manage the post- 
craniotomy pain were the objection of neurosurgeons (62%) 
and other causes of the anesthesiology department (20%): 
difficulty, unnecessariness and annoyingness of the post- 
craniotomy pain management. Fifty-five percent of anesthe-
siologists answered that more aggressive pain management is 
needed using PCA, and a majority of them preferred fentanyl 
(80%) as an opioid analgesic compared to morphine (9%), 
remifentanil (9%), and others (2%).
DISCUSSION
  It is known that over half of the patients (55%−69%) 
undergoing elective craniotomy surgery experienced moderate to 
severe pain postoperatively [2,3]. However, post-craniotomy 
pain is still ignored or underestimated.
  The present survey demonstrates that post-craniotomy pain 
management is inadequate and more aggressive pain manage-
ment is needed. There is certainly a need for standardized pain 
management protocols in Korea. 
  There was a difference in opinions towards post-craniotomy 
pain managements between neurosurgeons and anesthesiologists. 
Fifty-two percent of neurosurgeons answered that post-cranio-
tomy pain management is adequate, although 72% of them 
also said that more aggressive pain management is necessary. 
However, most anesthesiologists disagreed with the opinions of 
neurosurgeons. Only 8% of anesthesiologists replied that pain 
management after craniotomy is adequate. This discrepancy 
may result in several differences between the two groups for 
managing patients undergoing craniotomy. 
  Over 50% of neurosurgeons used NSAIDs as the first-line 
analgesic in patients undergoing craniotomy. This is quite 
different to other surveys in different countries [2,4,6]. NSAIDs 
are used as additional drugs and not as first-line drugs for the 
management of post-crainotomy pain in the UK [4,6]. 
Furthermore, NSAIDs are rarely used in the USA for post- 
craniotomy patients because of their antiplatelet effects [2].
  The safety and efficacy of NSAIDs for post-craniotomy 
analgesia arenot clear. Few studies have reported the risks of 
short-term postoperative use, whereas the risks of long-term 
usage have been well defined [14]. The most serious concern 
of NSAIDs in patients undergoing craniotomy is the hemostatic 
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complication due to antiplatelet effects of NSAIDs. In a 
retro-prospective study of neurosurgical patients, NSAIDs in 
the 2 weeks preceding surgery were considered a possible 
cause of postoperative hemorrhage [15]. Selective cyclooxy-
genase 2 (COX-2) inhibitors are safer than other nonselective 
NSAIDs in the view of hemostasis [16]. However, NSAIDs 
alone show inadequate analgesia after craniotomy, but can 
decrease the doses of opioids [17]. 
  Twenty-three percent of neurosurgeons (2% of anesthe-
siologist) used acetaminophen (paracetamol) as a first-line drug. 
Paracetamol is extremely safe and does not induce platelet 
dysfunction. However, paracetamol alone did not achieve 
adequate analgesia for post-craniotomy pain [18].
  In the present survey, approximately 10% of both neuro-
surgeons and anesthesiologists used weak opioid analgesics 
such as codeine and tramadol as the first-line drug. Codeine is 
widely used as the first-line opioid in the UK [4,6]. Codeine 
is not routinely used for postoperative pain management in 
other surgical procedures because of its weak analgesic effect 
but is still used because it does not affect the neurosurgical 
examination. However, the efficacy of codeine is questionable 
[19]. The analgesic effect of codeine is dependent on 
demethylation to morphine, and only 5-15% of the 
administered codeine is metabolized by this pathway [20,21]. 
In addition, codeine is ineffective in 15% of the population 
who have a dysfunction in this metabolic pathway [22]. 
Moreover, many clinicians have questioned the ethics of 
intramuscular injection to who have an intravenous fluid line.
  Tramadol was more frequently used compared to codeine 
because it is available for intravenous use in post-craniotomy 
patients in Korea. Tramadol inhibits the reuptake of serotonin 
and norepinephrine, as well as weakly binding to opioid 
receptors [23,24]. Therefore, it has similar side effects to 
opioids, including nausea, sedation and respiratory depression 
[25]. Higher incidence of nausea and vomiting than codeine 
[9] or morphine [26], which can result in increase of 
intracranial pressure, were reported. In addition, tramadol also 
exhibits potential risks of seizure [27]. However, in a recent 
study for craniotomy patients, combination treatment of 
tramadol and oxycodone provided better pain control and 
decreased the use of oxycodone and opioid side effects [28]. 
According to a recent survey by Kotak et al. [6], tramadol is 
used as a third or fourth line analgesic in 42% of the centers 
in the UK.
  In the present survey, 13% of neurosurgeons and 50% of 
anesthesiologists used strong opioids alone or combined with 
NSAIDs as first-line drugs. These results are comparable to 
other survey, in which, 30% of centers used morphine as a 
first-line opioid analgesic [6]. 
  The main reason to avoid the use of strong opioids in 
post-craniotomy patients is the concern that strong opioids may 
increase the ICP and interrupt the neurologic examination 
because of their side effects. Indeed, in this survey, the 
majority of respondents considered the side effects of opioids 
as the main reason preventing aggressive pain management in 
post-craniotomy patients. However, there were no increases 
observed in the adverse events of strong opioids compared 
with weak opioids in post-craniotomy patients. In many 
studies, morphine provided superior analgesia to both tramadol 
and codeine in patients following a neurosurgical procedure 
without increasing the opioid side effects [5,9,10,19] and 
morphine provided more consistent pain relief [10]. 
  Six of the surveyed hospitals (17%) used PCA for 
post-craniotomy analgesia on a case-by-case basis. This result 
is slightly higher than another survey [6] despite of the lower 
rate of opioid use. Patient-controlled analgesia (PCA) is widely 
used for management of postoperative pain after surgery. PCA 
using strong opioid analgesics has been shown to be a more 
effective method of pain control after craniotomy in 
cooperative patients [11,12,17]. PCA is generally performed by 
anesthesiologists in Korea. Nevertheless, 60% of the 
anesthesiologists answered that they did not involve the pain 
management for craniotomy patients due to the objection of 
neurosurgeons. 
  In fact, post-craniotomy pain management was mainly 
performed by neurosurgeons (91% of hospitals) in this survey. 
Several reasons were proposed for this. First, the majority of 
craniotomy patients are routinely admitted to the neurointensive 
care unit where they are not served by anesthesiologists like in 
most hospitals. Second, there is concern about opioids causing 
sedation and respiratory depression, so neurosurgeons dislike 
pain management by anesthesiologists who mainly use opioid 
analgesics in the recovery room. Third, anesthesiologists 
themselves do not want to be annoyed by pain management 
for craniotomy patients. 
  Seventy-one percent of neurosurgeons have experienced 
chronic pain after craniotomy. In a recent study, 56% of 
patients reported persistent pain 2 months after craniotomy 
(chronic headache) and 26% of patients reported neuropathic 
pain [29]. In that study, chronic pain was reduced by local 
infiltration of anesthetics to the surgical site at the end of the 
surgery. This means adequate postoperative pain management 
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may reduce the incidence of chronic pain in craniotomy 
patients.
  Post-craniotomy pain is common but underestimated. The 
management of this pain is very important because acute pain 
per se causes many physiologic adverse effects and delays 
recovery, consequently predisposing chronic pain. Many 
clinicians are in agreement that post-craniotomy pain is not 
adequately managed and more aggressive strategies are needed. 
Nevertheless, opioid analgesics are still avoided because of the 
concern of side effects despite no evidence to suggest 
increased risk when use carefully.   
  There is currently no consensus on post-craniotomy pain 
management in Korea. For this consensus, more studies for the 
safety and efficacy of several regimens or protocols and more 
attentions for the post-craniotomy pain will be needed.
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Appendix. Questionnaire of post-craniotomy pain management
1. Do you think postoperative pain managements are being well controlled on undergoing craniotomy patients?
2. Do you think more aggressive post-operative pain management in craniotomy patients is necessary?
If aggressive pain management for craniotomy patients is not being right fully carried out, what do you think the main problem would be?
3. What is the first-line analgesic for post-craniotomy patients in the immediate postoperative period?
4. If the above method is not effective, what additional drug is used for pain management?
5. In what way is pain management being controlled in post-craniotomy patients, and by what route is this analgesic delivered?
6. Are these drugs being used regularly or as required?
7. Do you think regular assessment of pain in post-craniotomy patients is needed?
8. Is a formal, documented pain assessment of post-craniotomy patients undertaken? If yes, what pain assessment tool is utilized?
9. Have you experienced a patient who referred post-craniotomy chronic pain, for example headache or pain in surgical region persisted for 
more than 2 months?
10. By whom is post-craniotomy pain management usually carried out in your hospital? 
If pain management is not carried out by anesthesiologists, what is the main reason?
* Questions for anesthesiologist only
11. Currently patient controlled analgesia (PCA) is largely being used for post-operative pain management. Do you think aggressive pain 
management using PCA in post-craniotomy patients is necessary?
12. If PCA is used, what kind of drugs will you be using?
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